Showing results (111-120 of 129) with videos related to
Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based StudyNaseem S Esteghamat, Ann Brunson, Aaron S Rosenberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trialsPrimo N Lara, Debora A Paterniti, Christine Chiechi, et al.JCI Insight|January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancerJeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.Thrombosis Research|January 20, 2024
Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in CaliforniaRenata Abrahão, Ann Brunson, Jessica Chubak, et al.Breast Cancer Research and Treatment|June 27, 2025
Trastuzumab therapy and new-onset hypertension in adolescents and young adults with breast cancerRenata Abrahão, Kathryn J Ruddy, Cecile A Laurent, et al.JMIR Research Protocols|May 23, 2020
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation StudyJane S Hankins, Nirmish Shah, Lisa DiMartino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibodyCarol M Richman, Sally J Denardo, Robert T O'Donnell, et al.British Journal of Haematology|August 19, 2011
Tapered oral dexamethasone for the acute chest syndrome of sickle cell diseaseCharles T Quinn, Marie J Stuart, Karen Kesler, et al.Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.Pageof 13